AP News

Movers roundup: Celgene, Clovis Oncology


Among the stock activity stories for Monday, Nov. 12, from AP Business News:

— Celgene Corp. shares rose after the drug maker said that its cancer drug Abraxane improved survival for patients with advanced pancreatic cancer.

— Shares of Clovis Oncology Inc. fell after the company said its drug CO-101 failed in a clinical trial as a treatment for pancreatic cancer.


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus